Publications by authors named "C Labeyrie"

Claim this Profile
T
Transthyretin variant cerebral amyloid angiopathy fulfilling the modified Boston criteria: Retrospective data from the Bicêtre hospital cohort.
J-B Brunet de Courssou, L Gorza, M Babin, G Nasser, C Ancelet, C Labeyrie

Rev Neurol (Paris)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis.
Antoine Gavoille, Emmanuelle Leray, Romain Marignier, Fabien Rollot, Romain Casey, Celine Labeyrie

Neurology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide Phenotypic and Genotypic Characterisation of 103 Patients With SH3TC2 Gene-Related Demyelinating Peripheral Neuropathy.
Pauline Jaubert, Camille Loret, Tanya Stojkovic, Shahram Attarian, Nathalie Bonello-Palot, Céline Labeyrie

Eur J Neurol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracutaneous Amyloid Deposition is Associated With Nerve Conduction Studies Deterioration in Presumed Asymptomatic Pathogenic Variant TTR Carriers.
Nina Schulz, Diane Beauvais, Cécile Cauquil, Céline Labeyrie, Iulia Iliescu

Eur J Neurol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kidney Outcomes in Patients With Hereditary Transthyretin Amyloid Nephropathy Treated With Transthyretin Stabilizers And Gene-Silencer Therapies.
Julien Dang, Justine Solignac, Sophie Ferlicot, Charlotte Mussini, Frank Bridoux, Céline Labeyrie

Kidney Int Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis